FNZ-13213-03309 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-08-05
Dose 1 — Pfizer-BioNTech
2022-09-21
Dose 2 — Pfizer-BioNTech
2022-10-07
Registered in v-safe
2022-10-07
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-12
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-26
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-11-02
Survey response — day 42, dose 2, under 3
MedDRA: Influenza, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school

Free text: Flus and rsv

MedDRA releases: 2024-11 · check-in free text available
2022-12-21
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-03-22
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-08-05	Pfizer-BioNTech	No
2	2022-09-21	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 42, dose 2, under 3

2022-11-02

Symptoms: Flus and rsv

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Influenza	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release